| Author(s) | García‐Alonso Y, García‐Hermoso A, Izquierdo M, Legarra‐Gorgoñon G, Ramírez‐Vélez R, Alonso‐Martínez A M |
|---|---|
| Journal / Source | https://onlinelibrary.wiley.com/doi/full/10.1111/ijpo.12923 |
| Date |
High dietary nucleotide consumption for one week increases circulating uric acid concentrations but does not compromise metabolic health: a randomised controlled trial
| Author(s) | Coelho M O, Monteyne A J, Kamalanathan I D, Najdanovic-Visak V, Finnigan T J, Stephens F B, Wall B T |
|---|---|
| Journal / Source | https://www.sciencedirect.com/science/article/pii/S2405457722002479 |
| Date |
Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial)
| Author(s) | Roughead E E, Pratt N L, Parfitt G, Rowett D, Kalisch-Ellett L M, Bereznicki L, Merlin T, Corlis M, Kang AC, Whitehouse J, Bilton R. |
|---|---|
| Journal / Source | https://academic.oup.com/ageing/article/51/4/afac092/6572256?login=true |
| Date |
Calibration and Cross-validation of Accelerometry in Children and Adolescents with Cystic Fibrosis
| Author(s) | Bianchim M S, McNarry M A, Evans R, Thia L, Barker A R, Williams C A, Denford S, Mackintosh K A |
|---|---|
| Journal / Source | https://www.tandfonline.com/doi/full/10.1080/1091367X.2022.2065919 |
| Date |
Elexacaftor-Tezacaftor-Ivacaftor improves exercise capacity in adolescents with cystic fibrosis
| Author(s) | Causer A J, Shute J, Cummings M, Shepherd A, Wallbanks S, Pulsford R, Bright V, Connett G, Saynor Z |
|---|---|
| Journal / Source | https://www.authorea.com/doi/full/10.22541/au.164985130.09443305 |
| Date |
